Abnormally expanded polyglutamine (polyQ) tracts provide a gain of toxic functions to nine otherwise unrelated human proteins and induce progressive neurodegenerative diseases. Over the past ten years, it was suggested that only polyQ tracts longer than a specific threshold adopt a particular structure, which would be the cause of the apparent polyQ length-dependent toxicity threshold observed in polyQ diseases. We have used a combination of biochemical and biophysical approaches to compare the structural properties of polyQ of pathogenic and non-pathogenic lengths under various conditions. We observe that pathogenic and non-pathogenic polyQ, as soluble species and upon interaction with a partner, during aggregation, or as mature aggregates...
Expanded polyglutamine (polyQ) repeats cause neurodegenerative disorders, but their cytotoxic struct...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...
Abnormally expanded polyglutamine (polyQ) tracts provide a gain of toxic functions to nine otherwise...
Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by the expansion of ...
Polyglutamine (polyQ) beta-stranded aggregates constitute the hallmark of Huntington disease. The di...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
AbstractPolyglutamine (polyQ) expansion leads to protein aggregation and neurodegeneration in Huntin...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Huntington’s disease (HD) results from expansions of polyglutamine stretches (polyQ) in the huntingt...
plasm of affected neurons. How the formation of these aggregates is mechanistically linked to cellul...
Although the genetic basis of polyglutamine diseases has been recognized for 20 years, their molecul...
AbstractAggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neuro...
Expanded polyglutamine (polyQ) repeats cause neurodegenerative disorders, but their cytotoxic struct...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...
Abnormally expanded polyglutamine (polyQ) tracts provide a gain of toxic functions to nine otherwise...
Polyglutamine (polyQ) diseases are inherited neurodegenerative disorders caused by the expansion of ...
Polyglutamine (polyQ) beta-stranded aggregates constitute the hallmark of Huntington disease. The di...
Protein aggregation is a key mechanism involved in neurodegeneration associated with Alzheimer’s, Pa...
AbstractPolyglutamine (polyQ) expansion leads to protein aggregation and neurodegeneration in Huntin...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Polyglutamine (polyQ) stretches exceeding a threshold length confer a toxic function to proteins tha...
Huntington’s disease (HD) results from expansions of polyglutamine stretches (polyQ) in the huntingt...
plasm of affected neurons. How the formation of these aggregates is mechanistically linked to cellul...
Although the genetic basis of polyglutamine diseases has been recognized for 20 years, their molecul...
AbstractAggregation of expanded polyglutamine (polyQ) seems to be the cause of various genetic neuro...
Expanded polyglutamine (polyQ) repeats cause neurodegenerative disorders, but their cytotoxic struct...
Huntington disease and other diseases of polyglutamine expansion are each caused by a different prot...
The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases...